| Susan O'donoghue, MD | |
|
110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 | |
| (202) 877-2848 | |
| (202) 877-6292 |
| Full Name | Susan O'donoghue |
|---|---|
| Gender | Female |
| Speciality | Cardiac Electrophysiology |
| Experience | 43 Years |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457306771 | NPI | - | NPPES |
| 025694300 | Medicaid | DC | |
| 6039693 | Medicaid | VA | |
| 076541400 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD17494 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Heart Institute Llc | 5698932960 | 171 |
| Medstar Heart Institute Llc | 5698932960 | 171 |
| Medstar Heart Institute Llc | 5698932960 | 171 |
News Archive
BioVectra Inc. announced today it has signed agreements with Sandoz Inc. of Princeton, New Jersey, for Sandoz to commercialize and market the Abbreviated New Drug Application (ANDA) for Docetaxel for injection, the generic version of Taxotere®, developed by BioVectra.
In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Entity Name | Medstar Heart Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528345378 PECOS PAC ID: 5698932960 Enrollment ID: O20120130000515 |
News Archive
BioVectra Inc. announced today it has signed agreements with Sandoz Inc. of Princeton, New Jersey, for Sandoz to commercialize and market the Abbreviated New Drug Application (ANDA) for Docetaxel for injection, the generic version of Taxotere®, developed by BioVectra.
In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
BioVectra Inc. announced today it has signed agreements with Sandoz Inc. of Princeton, New Jersey, for Sandoz to commercialize and market the Abbreviated New Drug Application (ANDA) for Docetaxel for injection, the generic version of Taxotere®, developed by BioVectra.
In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan O'donoghue, MD 110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 Ph: (202) 877-2848 | Susan O'donoghue, MD 110 Irving St Nw, Suite 2a38, Washington, DC 20010-2976 Ph: (202) 877-2848 |
News Archive
BioVectra Inc. announced today it has signed agreements with Sandoz Inc. of Princeton, New Jersey, for Sandoz to commercialize and market the Abbreviated New Drug Application (ANDA) for Docetaxel for injection, the generic version of Taxotere®, developed by BioVectra.
In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.
"The ongoing budget negotiations in Washington will require many hard choices to be made in the coming weeks," and "[w]ith respect to global health programs, these decisions may mean, literally, the difference between life and death," Peter Chernin - chair and CEO of the Chernin Group, chair of Malaria No More, and a board member of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria – writes in an AlertNet opinion piece.
It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
› Verified 6 days ago
Dr. Adefolaju Oketokun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |